Oppenheimer Comments On Cross Country (CCRN)

Oppenheimer provided color on Cross Country Healthcare CCRN in a research report published today, regarding Cross Country Healthcare's Q4 2010 earnings report. Oppenheimer has previously given Cross Country Healthcare a Perform rating.

In the report, Oppenheimer states, "The core business segments continued to struggle as revenues in Nurse and Allied Staffing (-9.1% y-y) and Locum Tenens (-16.1% y-y) led to an EBITDA margin of 4.6% (-140 bps y-y). While management is upbeat about the growth in the nursing segment, it expects the Locum Tenens segment to remain challenging."

Shares of Cross Country Healthcare closed Wednesday at $7.47, reflecting no change from Tuesday's market close.